首頁 > 市場調查報告書 > 製藥

精神疾病

市場調查報告書

商品編碼

2058289

精神健康治療市場：依疾病類型、藥物、通路和地區分類

Mental Disorder Treatment Market, By Disorder Type, By Medication, By Distribution Channel, By Geography

出版日期: 2026年05月04日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2026年精神健康治療市場價值為751億美元，預計到2033年將達到1,167億美元。預計從2026年到2033年，該市場將以6.6%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	751億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.60%	2033年市場規模預測：	1167億美元

精神疾病包括多種病症，例如憂鬱症、躁鬱症、思覺失調症、失智症和創傷後壓力症候群（PTSD）。這些精神疾病的治療方法包括藥物和心理治療。此外，用於治療這些精神疾病的藥物包括抗憂鬱症、抗焦慮藥物、抗精神病藥物和情緒穩定劑。

市場動態

為了鞏固在全球精神健康治療市場的地位，各大公司正致力於推出治療憂鬱症和躁鬱症等精神疾病的產品。例如，2017年，魯賓有限公司在美國市場推出了鹽酸安非他酮緩釋片，這是一種用於治療重度憂鬱症的抗憂鬱症。

本次調查的主要特點

本報告分析了全球精神健康治療市場的現狀和未來潛力。市場按疾病類型、藥物、分銷管道和地區進行細分。
本報告對全球心理健康治療市場進行了詳細分析，給出了預測期（2026-2033 年）的市場規模和複合年成長率（%）。
本報告揭示了各細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。此外，報告還深入分析了市場促進因素、限制因素、機會、各國市場前景以及主要參與者所採取的競爭策略。
本報告根據以下參數對全球心理健康治療市場的主要參與者進行了分析：公司概況、財務表現、產品系列、企業發展區域、主要發展和未來計劃。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊將能夠就未來的市場擴張和行銷策略做出明智的決策。
這份全球心理健康治療市場報告旨在為該行業的各種相關人員提供參考，包括投資者、產品開發商和製造商、經銷商、醫療機構、研究機構、新參與企業和金融分析師。
透過利用全球心理健康治療市場分析中使用的各種策略矩陣進行決策，相關人員可以從中受益匪淺。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第8章競爭情勢

公司簡介
- Allergan plc
- Eli Lilly and Company
- VistaGen Therapeutics
- Sanofi SA
- Novartis International AG
- Amneal Pharmaceuticals LLC
- Cipla Ltd
- Sun Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Lupin Limited
- Janssen Pharmaceutica
- Bristol Myers Squibb
- Sumitomo Dainippon Pharma Co., Ltd

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI4326

Mental Disorder Treatment Market is estimated to be valued at USD 75.1 Bn in 2026 and is expected to reach USD 116.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 75.1 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.60%	2033 Value Projection:	USD 116.7 Bn

The mental disorder include various different types of mental disorders such as depression, bipolar disorder, schizophrenia, dementia, post traumatic disorders, and others. These mental disorders are treated with the help of medications or psycho-therapies. Moreover, various medications used for the treatment of these mental disorders include anti-depressants, anti-anxiety medications, anti-psychotic medications, and mood stabilizing medication.

Market Dynamics

Key companies are focusing on product launches for the treatment of mental disorders such as depression, bipolar disorders to strengthen their position in the global mental disorder treatment market. For instance, in 2017, Lupin Limited, launched its anti-depressant, Bupropion Hydrochloride extended release tablets, indicated for the treatment of major depressive disorder, in the U.S. market.

Key features of the study

This report studies the current scenario as well as the future potential of the global mental disorder treatment market. The market for is segmented on basis of disorder type, medication, distribution channel, and region.
This report provides in-depth analysis of the global mental disorder treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR) (%) for the forecast period (2026-2033)
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
It profiles leading players in the global mental disorder treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
The global mental disorder treatment market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global mental disorder treatment market

Market Segmentation

By Disorder Type (Revenue, USD Bn, 2021-2033)
- Depression
- Bipolar Disorder
- Schizophrenia
- Dementia
- Post-traumatic stress disorder
- Others
By Medication (Revenue, USD Bn, 2021-2033)
- Anti-depressants
- Anti-anxiety
- Mood Stabilizing Medication
- Antipsychotic Medications
By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Mental Disorder Treatment Market, By Region: (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- Allergan plc
- Eli Lilly and Company
- VistaGen Therapeutics
- Sanofi S.A
- Novartis International AG
- Mylan N.V.
- Amneal Pharmaceuticals LLC
- Cipla Ltd
- Sun Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Lupin Limited
- Janssen Pharmaceutica
- Bristol Myers Squibb
- Sumitomo Dainippon Pharma Co., Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Disorder Type
- Market Snapshot, By Medication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Opportunities
Impact Analysis
Key Developments
New Product Launches/Approvals
Merger-Acquisition Scenario
Regulatory Scenario
Pipeline Analysis
Epidemiology
PEST Analysis
Reimbursement

4. Global Mental Disorder Treatment Market, By Disorder Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Depression
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Bipolar Disorder
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Schizophrenia
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Dementia
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Post-traumatic Stress Disorder
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Mental Disorder Treatment Market, By Medication, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Anti-depressants
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Anti-anxiety
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Mood Stabilizing Medication
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Antipsychotic Medications
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Mental Disorder Treatment Market, By Distribution Channel, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

7. Global Mental Disorder Treatment Market, By Region, 2021-2033 (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 - 2033
North America
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - U.S.
  - Canada
Latin America
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Company Profiles
- Allergan plc
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Eli Lilly and Company
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- VistaGen Therapeutics
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Sanofi S.A
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Novartis International AG
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
  - Mylan N.V.
- Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Amneal Pharmaceuticals LLC
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Cipla Ltd
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Sun Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Glenmark Pharmaceuticals Limited
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Lupin Limited
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Janssen Pharmaceutica
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Bristol Myers Squibb
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Sumitomo Dainippon Pharma Co., Ltd
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

恐慌症治療市場分析及預測（至2035年）：依類型、產品類型、服務、技術、應用、最終使用者、模式及階段分類

全球恐慌症治療市場按藥物類別、給藥途徑、分銷管道和地區分類

FAQ

精神健康治療市場：依疾病類型、藥物、通路和地區分類